| AEREA Y POSTAL EX-IAAC | 2024 | 6.998 | KG | COLISTIMETHATE SODIUM, S/M, S/M COLISTIMETHATE SODIUM MATERIA PRIMA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN BOU = UNIDADES | CHINA | SWITZERLAND | 25366.1 |
| AEREA Y POSTAL EX-IAAC | 2024 | 65 | KG | 9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2- 9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2- MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KIL | CHINA | CHINA | 35510 |
| AEREA Y POSTAL EX-IAAC | 2024 | 12 | KG | COLISTIMETATO SODICO ESTERIL, S/M, S/M COLISTIMETATO SODICO ESTERIL MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOGRAMOS | CHINA | SWITZERLAND | 42927.5 |
| AEREA Y POSTAL EX-IAAC | 2024 | 60 | KG | 9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2- 9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2- MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KIL | CHINA | CHINA | 32740 |
| AEREA Y POSTAL EX-IAAC | 2024 | 33.39 | KG | COLISTIMETATO SODICO ESTERIL, S/M, S/M COLISTIMETATO SODICO ESTERIL MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN GRAMOS | CHINA | SWITZERLAND | 84209.4 |
| AEREA Y POSTAL EX-IAAC | 2024 | 55 | KG | 9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2- 9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2- MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KIL | CHINA | CHINA | 29965 |
| AEREA Y POSTAL EX-IAAC | 2024 | 0.064 | KG | CLINDAMICINA FOSFATO (USP), UPS, S/M CLINDAMYCIN PHOSPHATE (250 MG) ESTANDARES PRIMARIOS PARA ANALISIS EN EL LABORATORIO CLINDAMICINA FOSFATO (USP), UPS, S/M | SPAIN | UNITED STATES | 384.14 |
| AEREA Y POSTAL EX-IAAC | 2024 | 80 | KG | 4-amino-N-(1-ethyl-2-pyrrolidinyl) Methyl) 5-(ethylsulfonyl) -2-methoxybenzamide, S/M, S/M 4-amino-N-(1-ethyl-2-pyrrolidinyl) Methyl) 5-(ethylsulfonyl) -2-methoxybenzamide Materia prima para fabricación de medicamentos COMERCIALIZADO EN KILOGRAMOS | INDIA | PANAMA | 11024 |
| AEREA Y POSTAL EX-IAAC | 2024 | 200 | KG | 3-chloro-7-D-(2 phenyl Glycinamide)-3 Chloro-Cephem-4-Carboxylyc acid, Monohydrate, S/M, S 3-chloro-7-D-(2 phenyl Glycinamide)-3 Chloro-Cephem-4-Carboxylyc acid, Monohydrate MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 50774 |
| AEREA Y POSTAL EX-IAAC | 2024 | 100 | KG | (6R, 7R)-7-[(R)-2-AMINO-2-(P-HYDROXYPHENYL) ACETAMIDO]-3-METHYL-8-OXO-5- THIA-1-AZABICYCLO (6R, 7R)-7-[(R)-2-AMINO-2-(P-HYDROXYPHENYL) ACETAMIDO]-3-METHYL-8-OXO-5- THIA-1-AZABICYCLO MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | INDIA | INDIA | 7129.62 |
| AEREA Y POSTAL EX-IAAC | 2024 | 0.227 | KG | CEFUROXIMA AXETIL DELTA, UPS, S/M ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO ((1RS,6R,7R)-1-ACETOXYETHYL 3-((CARBAMOYLOXY)METHYL))-7-7((Z PRESENTACION: 10 MG, CODIGO: 1098231, LOTE: R12220 CEFUROXIME AXETIL DELTA-3-ISOMERS (10 MG), CEFUROXIMA | INDIA | UNITED STATES | 1605.84 |
| AEREA Y POSTAL EX-IAAC | 2024 | 375 | KG | 5-THIA-1-AZABICYCLO[4.2.0] OCT-2-ENE-2-CARBOXYLIC ACID3-[[(AMINOCARBONYL)OXY]METHYL]-7-[[2 5-THIA-1-AZABICYCLO[4.2.0] OCT-2-ENE-2-CARBOXYLIC ACID3-[[(AMINOCARBONYL)OXY]METHYL]-7-[[2 MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | INDIA | INDIA | 58824.4 |